MIRA: MIRA Pharmaceuticals, Inc. Stock

by  •  • Comments Off on MIRA: MIRA Pharmaceuticals, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 19.04
Enterprise Value ($M) 14.90
Book Value ($M) 3.57
Book Value / Share 0.22
Price / Book 5.33
NCAV ($M) 3.54
NCAV / Share 0.21
Price / NCAV 5.38

Profitability (mra)
Return on Invested Capital (ROIC) -3.15
Return on Assets (ROA) -2.28
Return on Equity (ROE) -2.57

Liquidity (mrq)
Quick Ratio 6.11
Current Ratio 6.11

Balance Sheet (mrq) ($M)
Current Assets 4.23
Assets 4.27
Liabilities 0.69
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)
Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-16 10-Q/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A (Amendment No. 1)
2024-08-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-04-01 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-02-04 99,272 220,876 44.94
2025-02-03 66,452 185,285 35.86
2025-01-31 80,522 209,174 38.50
2025-01-30 196,985 621,218 31.71

(click for more detail)

Similar Companies
MBRX – Moleculin Biotech, Inc. ME – 23andMe Holding Co.
MEIP – MEI Pharma, Inc. MLTX – MoonLake Immunotherapeutics
MNPR – Monopar Therapeutics Inc.


Financial data and stock pages provided by
Fintel.io